Mich. Federal Judge Dismisses Action Targeting Janssen’s Invega

DETROIT — A Michigan federal judge has dismissed an action in which a man accused Janssen Pharmaceuticals of failing to warn that its antipsychotic Invega Sustenna can cause an adverse reaction in patients who consumed cannabis.

In a Feb. 6 order, Judge Thomas Ludington of the U.S. District Court for the Eastern District of Michigan adopted a magistrate judge’s finding that the plaintiff failed to plead a link between his alleged injuries and Invega.

Pro se plaintiff Patrick Groulx alleges that on Nov. 9, 2020, he admitted himself to a Michigan hospital to “seek guidance on dealing with harmful …